JMP Securities reiterated coverage on Neuronetics with a new price target

10/14/21 8:41:45 AM ET

Medical/Dental Instruments

Health Care

JMP Securities reiterated coverage of Neuronetics with a rating of Market Outperform and set a new price target of $12.00 from $18.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$STIM

Date	Price Target	Rating	Analyst
8/13/2024		Outperform → Mkt Perform	William Blair
10/14/2021	$18.00 → $12.00	Market Outperform	JMP Securities
10/13/2021		Outperform → Mkt Perform	William Blair
10/13/2021		Buy → Neutral	BTIG